![Yair Fisher](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yair Fisher
Chief Tech/Sci/R&D Officer at Glixogen Therapeutics Ltd.
Yair Fisher active positions
Companies | Position | Start | End |
---|---|---|---|
Glixogen Therapeutics Ltd.
![]() Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Chief Tech/Sci/R&D Officer | 01/12/2018 | - |
Chief Executive Officer | 01/12/2018 | - |
Career history of Yair Fisher
Training of Yair Fisher
Ben-Gurion University of the Negev | Doctorate Degree |
Statistics
International
Israel | 3 |
Operational
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Sectoral
Commercial Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Glixogen Therapeutics Ltd.
![]() Glixogen Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Glixogen Therapeutics Ltd. engages in the development of treatment to enhance remyelination in neurodegenerative disorders. The company was founded on October 11, 2018 and is headquartered in Ness Ziona, Israel. | Commercial Services |
- Stock Market
- Insiders
- Yair Fisher
- Experience